Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis
Conditions
Scleroderma, Systemic · Digital Ulcer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Calgary, Calgary, Alberta, Canada
Contact: Study coordinator (Larche', MD)Dalhousie University, Halifax, Nova Scotia, Canada
Contact: Study coordinator (Sutton, MD)Saint Joseph Health Care Centre, London, Ontario, Canada
Contact: Study coordinator (Clinical Study Administrator) · jillian.bylsma@sjhc.london.on.ca · +1-519.646.6100Contact: Principal Investigator (Division Head Rheumotology)The Ottawa Hospital, Ottawa, Ontario, Canada
Contact: Study coordinator (Maltez, MD)Mount Sinai Health System, Toronto, Ontario, Canada
Contact: Study coordinator (Director, Toronto Scleroderma Program) · Shafina.hasmani@sinaihealth.ca · +1-416-586-4800Contact: Study coordinator (Shafina Health)
Study leads
Lukban
Study Director
Primus Pharmaceuticals